Biological role of bacterial inclusion bodies: a model for amyloid aggregation

被引:57
作者
Garcia-Fruitos, Elena [1 ,2 ,3 ]
Sabate, Raimon [1 ,4 ]
de Groot, Natalia S. [1 ,4 ]
Villaverde, Antonio [1 ,2 ,3 ]
Ventura, Salvador [1 ,4 ]
机构
[1] Univ Autonoma Barcelona, Inst Biotechnol & Biomed, E-08193 Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain
[3] CIBER BBN, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain
关键词
aggregation; amyloid; FTIR; inclusion bodies; protein folding; protein quality; recombinant proteins; PROTEIN AGGREGATION; CONFORMATIONAL QUALITY; ALZHEIMERS-DISEASE; FIBRIL FORMATION; CHAPERONE DNAK; IN-VIVO; SOLUBILITY; SEQUENCE; PREDICTION; HET-S(218-289);
D O I
10.1111/j.1742-4658.2011.08165.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inclusion bodies are insoluble protein aggregates usually found in recombinant bacteria when they are forced to produce heterologous protein species. These particles are formed by polypeptides that cross-interact through sterospecific contacts and that are steadily deposited in either the cell's cytoplasm or the periplasm. An important fraction of eukaryotic proteins form inclusion bodies in bacteria, which has posed major problems in the development of the biotechnology industry. Over the last decade, the fine dissection of the quality control system in bacteria and the recognition of the amyloid-like architecture of inclusion bodies have provided dramatic insights on the dynamic biology of these aggregates. We discuss here the relevant aspects, in the interface between cell physiology and structural biology, which make inclusion bodies unique models for the study of protein aggregation, amyloid formation and prion biology in a physiologically relevant background.
引用
收藏
页码:2419 / 2427
页数:9
相关论文
共 74 条
  • [1] Molecular chaperones and protein quality control
    Bukau, Bernd
    Weissman, Jonathan
    Horwich, Arthur
    [J]. CELL, 2006, 125 (03) : 443 - 451
  • [2] Protein aggregated into bacterial inclusion bodies does not result in protection from proteolytic digestion
    Carbonell, X
    Villaverde, A
    [J]. BIOTECHNOLOGY LETTERS, 2002, 24 (23) : 1939 - 1944
  • [3] Amyloid-like properties of bacterial inclusion bodies
    Carrió, M
    González-Montalbán, N
    Vera, A
    Villaverde, A
    Ventura, S
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2005, 347 (05) : 1025 - 1037
  • [4] Localization of chaperones DnaK and GroEL in bacterial inclusion bodies
    Carrió, MM
    Villaverde, A
    [J]. JOURNAL OF BACTERIOLOGY, 2005, 187 (10) : 3599 - 3601
  • [5] Protein aggregation as bacterial inclusion bodies is reversible
    Carrió, MM
    Villaverde, A
    [J]. FEBS LETTERS, 2001, 489 (01) : 29 - 33
  • [6] Construction and deconstruction of bacterial inclusion bodies
    Carrió, MM
    Villaverde, A
    [J]. JOURNAL OF BIOTECHNOLOGY, 2002, 96 (01) : 3 - 12
  • [7] Deciphering the role of the thermodynamic and kinetic stabilities of SH3 domains on their aggregation inside bacteria
    Castillo, Virginia
    Espargaro, Alba
    Gordo, Veronica
    Vendrell, Josep
    Ventura, Salvador
    [J]. PROTEOMICS, 2010, 10 (23) : 4172 - 4185
  • [8] Rationalization of the effects of mutations on peptide and protein aggregation rates
    Chiti, F
    Stefani, M
    Taddei, N
    Ramponi, G
    Dobson, CM
    [J]. NATURE, 2003, 424 (6950) : 805 - 808
  • [9] Protein misfolding, functional amyloid, and human disease
    Chiti, Fabrizio
    Dobson, Christopher M.
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 : 333 - 366
  • [10] AGGRESCAN:: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides
    Conchillo-Sole, Oscar
    de Groot, Natalia S.
    Aviles, Francesc X.
    Vendrell, Josep
    Daura, Xavier
    Ventura, Salvador
    [J]. BMC BIOINFORMATICS, 2007, 8 (1)